Equity Overview
Price & Market Data
Price: $0.11
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $246,562
Daily Volume: 0
Performance Metrics
1 Week: 29.41%
1 Month: 19.70%
3 Months: 10.00%
6 Months: 691.4%
1 Year: -63.33%
YTD: 18.79%
Details
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. Its lead product candidate is ImMucin, a MUC1 SP-based vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. The company is headquartered in Toronto, Canada.